Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Reviews
  • Published:

Voiding dysfunction due to detrusor underactivity: an overview

Key Points

  • By default, the lower urinary tract is maintained in storage mode; voiding involves a sequence of behavioural and physiological steps, which permit passage of urine when safe and socially appropriate

  • Detrusor underactivity (DUA) represents a contraction of reduced strength and/or duration during voiding, resulting in prolonged bladder emptying and/or failure to completely empty the bladder within a normal timespan

  • Aetiological factors relevant to DUA include ageing, bladder outlet obstruction, denervation, and neurological disease

  • Urodynamic diagnostic approaches assess bladder pressures and urinary flow, or detrusor pressure changes upon interruption of voiding; generally, fluctuating, poorly sustained detrusor contraction and a low flow rate characterize DUA

  • Therapy is based on the presenting symptoms, with catheterization (usually intermittent) representing the mainstay treatment in symptomatic patients; pharmacological therapies are limited by low efficacy, adverse effects, and marginal quality-of-life improvements

  • Potential therapeutic strategies include attempts to increase detrusor contractility or modulate afferent nerve activity, but the development of new therapeutic options for DUA faces substantial challenges

Abstract

Detrusor underactivity (DUA) is defined as a voiding contraction of reduced strength and/or duration, which prolongs urination and/or prevents complete emptying of the bladder within a 'normal' period of time. This issue is associated with voiding and postmicturition urinary symptoms, and can predispose to urinary infections and acute urinary retention. The aetiology of DUA is influenced by multiple factors, including ageing, bladder outlet obstruction, neurological disease, and autonomic denervation. The true prevalence of this condition remains unknown, as most data come from referral populations. Urodynamic testing is used to diagnose the condition, either by assessing the relationship between bladder pressures and urinary flow, or by interrupting voiding to measure detrusor pressure change under isovolumetric conditions. Current treatments for DUA have poor efficacy and tolerability, and often fail to improve quality of life; muscarinic receptor agonists, in particular, have limited efficacy and frequent adverse effects. Bladder emptying might be achieved through Valsalva straining, and intermittent or indwelling catheterization, although sacral nerve stimulation can reduce dependency on catheterization. Novel stem-cell-based therapies have been attempted; however, new drugs that increase contractility are currently largely conceptual, and the complex pathophysiology of DUA, difficulty achieving organ specificity of treatment, the limited availability of animal models, and the subjective nature of current outcome measures must be addressed to facilitate the development of such agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Results of an invasive urodynamic assessment in a patient with DUA.

Similar content being viewed by others

References

  1. Osman, N. I. et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur. Urol. 65, 389–398 (2014).

    PubMed  Google Scholar 

  2. Abrams, P., Cardozo, L., Khoury, S. & Wein, A. (eds). Incontinence 5th edn (ICUD–EAU, 2013).

    Google Scholar 

  3. Abrams, P. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 21, 167–178 (2002).

    PubMed  Google Scholar 

  4. Schafer, W. et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol. Urodyn. 21, 261–274 (2002).

    PubMed  Google Scholar 

  5. Alexander, S. & Rowan, D. Treatment of patients with hypotonic bladder by radio-implant. Br. J. Surg. 59, 302 (1972).

    PubMed  CAS  Google Scholar 

  6. Kirby, R. S. et al. Non-obstructive detrusor failure. A urodynamic, electromyographic, neurohistochemical and autonomic study. Br. J. Urol. 55, 652–659 (1983).

    PubMed  CAS  Google Scholar 

  7. Resnick, N. M. & Yalla, S. V. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA 257, 3076–3081 (1987).

    PubMed  CAS  Google Scholar 

  8. Griffiths, D. J. & Fowler, C. J. The micturition switch and its forebrain influences. Acta Physiol. (Oxford) 207, 93–109 (2013).

    CAS  Google Scholar 

  9. Sadananda, P., Vahabi, B. & Drake, M. J. Bladder outlet physiology in the context of lower urinary tract dysfunction. Neurourol. Urodyn. 30, 708–713 (2011).

    PubMed  Google Scholar 

  10. de Groat, W. C. & Wickens, C. Organization of the neural switching circuitry underlying reflex micturition. Acta Physiol. (Oxford) 207, 66–84 (2013).

    CAS  Google Scholar 

  11. Birder, L. et al. Neural control of the lower urinary tract: peripheral and spinal mechanisms. Neurourol. Urodyn. 29, 128–139 (2010).

    PubMed  PubMed Central  CAS  Google Scholar 

  12. Drake, M. J. The integrative physiology of the bladder. Ann. R. Coll. Surg. Engl. 89, 580–585 (2007).

    PubMed  PubMed Central  Google Scholar 

  13. Gilpin, S. A., Gilpin, C. J., Dixon, J. S., Gosling, J. A. & Kirby, R. S. The effect of age on the autonomic innervation of the urinary bladder. Br. J. Urol. 58, 378–381 (1986).

    PubMed  CAS  Google Scholar 

  14. Gosling, J. A., Gilpin, S. A., Dixon, J. S. & Gilpin, C. J. Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J. Urol. 136, 501–504 (1986).

    PubMed  CAS  Google Scholar 

  15. Drake, M. J. et al. Structural and functional denervation of human detrusor after spinal cord injury. Lab. Invest. 80, 1491–1499 (2000).

    PubMed  CAS  Google Scholar 

  16. Saito, M., Yokoi, K., Ohmura, M. & Kondo, A. Effects of partial outflow obstruction on bladder contractility and blood flow to the detrusor: comparison between mild and severe obstruction. Urol. Int. 59, 226–230 (1997).

    PubMed  CAS  Google Scholar 

  17. Schroder, A. et al. Effect of chronic bladder outlet obstruction on blood flow of the rabbit bladder. J. Urol. 165, 640–646 (2001).

    PubMed  CAS  Google Scholar 

  18. Deirmentzoglou, S., Giannitsas, K., Perimenis, P., Petsas, T. & Athanasopoulos, A. Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms. Urology 80, 66–70 (2012).

    PubMed  Google Scholar 

  19. Brierly, R. D., Hindley, R. G., McLarty, E., Harding, D. M. & Thomas, P. J. A prospective controlled quantitative study of ultrastructural changes in the underactive detrusor. J. Urol. 169, 1374–1378 (2003).

    PubMed  CAS  Google Scholar 

  20. Elbadawi, A., Yalla, S. V. & Resnick, N. M. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J. Urol. 150, 1657–1667 (1993).

    PubMed  CAS  Google Scholar 

  21. Schneider, T., Hein, P., Michel-Reher, M. B. & Michel, M. C. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder. Naunyn Schmiedebergs Arch. Pharmacol. 372, 71–78 (2005).

    PubMed  CAS  Google Scholar 

  22. Lluel, P. et al. Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders. Fundam. Clin. Pharmacol. 17, 633–641 (2003).

    PubMed  CAS  Google Scholar 

  23. Suskind, A. M. & Smith, P. P. A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr. Urol. Rep. 10, 347–351 (2009).

    PubMed  Google Scholar 

  24. Smith, P. P. Aging and the underactive detrusor: a failure of activity or activation? Neurourol. Urodyn. 29, 408–412 (2010).

    PubMed  Google Scholar 

  25. van Koeveringe, G. A., Vahabi, B., Andersson, K. E., Kirschner-Herrmans, R. & Oelke, M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol. Urodyn. 30, 723–728 (2011).

    PubMed  CAS  Google Scholar 

  26. Kohan, A. D., Danziger, M., Vaughan, E. D. Jr & Felsen, D. Effect of aging on bladder function and the response to outlet obstruction in female rats. Urol. Res. 28, 33–37 (2000).

    PubMed  CAS  Google Scholar 

  27. Thomas, A. W., Cannon, A., Bartlett, E., Ellis-Jones, J. & Abrams, P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 93, 745–750 (2004).

    PubMed  CAS  Google Scholar 

  28. Al-Hayek, S., Thomas, A. & Abrams, P. Natural history of detrusor contractility—minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand. J. Urol. Nephrol. Suppl. 215, 101–108 (2004).

    Google Scholar 

  29. Abarbanel, J. & Marcus, E. L. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology 69, 436–440 (2007).

    PubMed  Google Scholar 

  30. Araki, I., Matsui, M., Ozawa, K., Takeda, M. & Kuno, S. Relationship of bladder dysfunction to lesion site in multiple sclerosis. J. Urol. 169, 1384–1387 (2003).

    PubMed  Google Scholar 

  31. Kim, T. G., Yoo, K. H., Jeon, S. H., Lee, H. L. & Chang, S. G. Effect of dominant hemispheric stroke on detrusor function in patients with lower urinary tract symptoms. Int. J. Urol. 17, 656–660 (2010).

    PubMed  Google Scholar 

  32. Kristensen, G. B., Frimodt-Moller, P. C., Poulsen, H. K. & Ulbak, S. Persistent bladder dysfunction after surgical and combination therapy of cancer of the cervix uteri stages Ib and IIa. Gynecol. Oncol. 18, 38–42 (1984).

    PubMed  CAS  Google Scholar 

  33. Long, Y., Yao, D. S., Pan, X. W. & Ou, T. Y. Clinical efficacy and safety of nerve-sparing radical hysterectomy for cervical cancer: a systematic review and meta-analysis. PLoS ONE 9, e94116 (2014).

    PubMed  PubMed Central  Google Scholar 

  34. Puri, P. & Gosemann, J. H. Variants of Hirschsprung disease. Semin. Pediatr. Surg. 21, 310–318 (2012).

    PubMed  Google Scholar 

  35. Burakgazi, A. Z., Alsowaity, B., Burakgazi, Z. A., Unal, D. & Kelly, J. J. Bladder dysfunction in peripheral neuropathies. Muscle Nerve 45, 2–8 (2012).

    PubMed  Google Scholar 

  36. Kirschner-Hermanns, R. et al. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol. Urodyn. 31, 359–364 (2012).

    PubMed  Google Scholar 

  37. Buntzen, S., Nordgren, S., Delbro, D. & Hulten, L. Anal and rectal motility responses to distension of the urinary bladder in man. Int. J. Colorectal Dis. 10, 148–151 (1995).

    PubMed  CAS  Google Scholar 

  38. Tan, T. L., Lieu, P. K. & Ding, Y. Y. Urinary retention in hospitalised older women. Ann. Acad. Med. Singapore 30, 588–592 (2001).

    PubMed  CAS  Google Scholar 

  39. Drake, M. J., Nixon, P. M. & Crew, J. P. Drug-induced bladder and urinary disorders. Incidence, prevention and management. Drug Saf. 19, 45–55 (1998).

    PubMed  CAS  Google Scholar 

  40. Zhu, Q. et al. Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents. J. Urol. 166, 1136–1141 (2001).

    PubMed  CAS  Google Scholar 

  41. DasGupta, R. & Fowler, C. J. The management of female voiding dysfunction: Fowler's syndrome—a contemporary update. Curr. Opin. Urol. 13, 293–299 (2003).

    PubMed  Google Scholar 

  42. Osman, N. I. & Chapple, C. R. Fowler's syndrome-a cause of unexplained urinary retention in young women? Nat. Rev. Urol. 11, 87–98 (2014).

    PubMed  Google Scholar 

  43. Huang, A. J. et al. Clinical significance of postvoid residual volume in older ambulatory women. J. Am. Geriatr. Soc. 59, 1452–1458 (2011).

    PubMed  Google Scholar 

  44. Cucchi, A., Quaglini, S., Guarnaschelli, C. & Rovereto, B. Urodynamic findings suggesting two-stage development of idiopathic detrusor underactivity in adult men. Urology 70, 75–79 (2007).

    PubMed  Google Scholar 

  45. Hamdi, A. et al. Severe post-renal acute kidney injury, post-obstructive diuresis and renal recovery. BJU Int. 110, E1027–E1034 (2012).

    PubMed  CAS  Google Scholar 

  46. Chancellor, M. B., Blaivas, J. G., Kaplan, S. A. & Axelrod, S. Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow. J. Urol. 145, 810–812 (1991).

    PubMed  CAS  Google Scholar 

  47. Abrams, P. H. & Griffiths, D. J. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br. J. Urol. 51, 129–134 (1979).

    PubMed  CAS  Google Scholar 

  48. Griffiths, D. J. Editorial: bladder failure—a condition to reckon with. J. Urol. 169, 1011–1012 (2003).

    PubMed  Google Scholar 

  49. Griffiths, D. J., Harrison, G., Moore, K. & McCracken, P. Variability of post-void residual urine volume in the elderly. Urol. Res. 24, 23–26 (1996).

    PubMed  CAS  Google Scholar 

  50. Dunsmuir, W. D., Feneley, M., Corry, D. A., Bryan, J. & Kirby, R. S. The day-to-day variation (test–retest reliability) of residual urine measurement. Br. J. Urol. 77, 192–193 (1996).

    PubMed  CAS  Google Scholar 

  51. Tan, T. L., Bergmann, M. A., Griffiths, D. & Resnick, N. M. Stop test or pressure-flow study? Measuring detrusor contractility in older females. Neurourol. Urodyn. 23, 184–189 (2004).

    PubMed  Google Scholar 

  52. Abrams, P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 84, 14–15 (1999).

    PubMed  CAS  Google Scholar 

  53. Griffiths, C. J. et al. A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressure. J. Urol. 174, 1323–1326; discussion 1326; author reply 1326 (2005).

    PubMed  CAS  Google Scholar 

  54. Schafer, W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J. Urol. 13, 47–58 (1995).

    PubMed  CAS  Google Scholar 

  55. Griffiths, D. Detrusor contractility—order out of chaos. Scand. J. Urol. Nephrol. Suppl. 215, 93–100 (2004).

    Google Scholar 

  56. Robertson, A. S., Griffiths, C. & Neal, D. E. Conventional urodynamics and ambulatory monitoring in the definition and management of bladder outflow obstruction. J. Urol. 155, 506–511 (1996).

    PubMed  CAS  Google Scholar 

  57. Morita, M., Okamoto, M., Ochi, K. & Takeuchi, M. Isometric detrusor pressure in the male patient: a comparison between voluntary urethral sphincter contraction and forced penile compression techniques. J. Urol. 134, 1161–1165 (1985).

    PubMed  CAS  Google Scholar 

  58. Cucchi, A., Quaglini, S. & Rovereto, B. Proposal for a urodynamic redefinition of detrusor underactivity. J. Urol. 181, 225–229 (2009).

    PubMed  Google Scholar 

  59. van Koeveringe, G. A., Rahnama'i, M. S. & Berghmans, B. C. The additional value of ambulatory urodynamic measurements compared with conventional urodynamic measurements. BJU Int. 105, 508–513 (2010).

    PubMed  Google Scholar 

  60. Sullivan, M. P. & Yalla, S. V. Penile urethral compression-release maneuver as a non-invasive screening test for diagnosing prostatic obstruction. Neurourol. Urodyn. 19, 657–669 (2000).

    PubMed  CAS  Google Scholar 

  61. Blake, C. & Abrams, P. Noninvasive techniques for the measurement of isovolumetric bladder pressure. J. Urol. 171, 12–19 (2004).

    PubMed  Google Scholar 

  62. Drake, M. J. et al. Neurologic urinary and faecal incontinence in Incontinence 5th edn (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A.) 827–1000 (ICUD–EAU, 2013).

    Google Scholar 

  63. Parsons, B. A., Narshi, A. & Drake, M. J. Success rates for learning intermittent self-catheterisation according to age and gender. Int. Urol. Nephrol. 44, 1127–1131 (2012).

    PubMed  Google Scholar 

  64. Diokno, A. C., Sonda, L. P., Hollander, J. B. & Lapides, J. Fate of patients started on clean intermittent self-catheterization therapy 10 years ago. J. Urol. 129, 1120–1122 (1983).

    PubMed  CAS  Google Scholar 

  65. Tenke, P., Koves, B. & Johansen, T. E. An update on prevention and treatment of catheter-associated urinary tract infections. Curr. Opin. Infect. Dis. 27, 102–107 (2014).

    PubMed  Google Scholar 

  66. Harada, T. et al. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity. Biol. Pharm. Bull. 33, 653–658 (2010).

    PubMed  CAS  Google Scholar 

  67. Barrett, D. M. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J. Urol. 126, 640–642 (1981).

    PubMed  CAS  Google Scholar 

  68. Riedl, C. R. et al. Electromotive administration o intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J. Urol. 164, 2108–2111 (2000).

    PubMed  CAS  Google Scholar 

  69. Krishnamoorthy, S. & Kekre, N. S. Detrusor underactivity: to tone or not to tone the bladder? Indian J. Urol. 25, 407–408 (2009).

    PubMed  PubMed Central  Google Scholar 

  70. Barendrecht, M. M., Oelke, M., Laguna, M. P. & Michel, M. C. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 99, 749–752 (2007).

    PubMed  CAS  Google Scholar 

  71. Yamanishi, T. et al. Combination of a cholinergic drug and an α-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int. J. Urol. 11, 88–96 (2004).

    PubMed  CAS  Google Scholar 

  72. van Kerrebroeck, P. E. et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J. Urol. 178, 2029–2034 (2007).

    PubMed  Google Scholar 

  73. Datta, S. N. et al. Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int. 101, 192–196 (2008).

    PubMed  Google Scholar 

  74. Everaert, K., Plancke, H., Lefevere, F. & Oosterlinck, W. The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br. J. Urol. 79, 702–707 (1997).

    PubMed  CAS  Google Scholar 

  75. Radziszewski, K. Outcomes of electrical stimulation of the neurogenic bladder: results of a two-year follow-up study. NeuroRehabilitation 32, 867–873 (2013).

    PubMed  Google Scholar 

  76. Choi, E. K. et al. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience. J. Pediatr. Urol. 9, 798–803 (2013).

    PubMed  Google Scholar 

  77. Gakis, G. et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J. Urol. 185, 593–599 (2011).

    PubMed  Google Scholar 

  78. Stanasel, I., Mirzazadeh, M. & Smith, J. J. 3rd. Bladder tissue engineering. Urol. Clin. North Am. 37, 593–599 (2010).

    PubMed  Google Scholar 

  79. Chancellor, M. B. et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol. Urodyn. 19, 279–287 (2000).

    PubMed  CAS  Google Scholar 

  80. Gopinath, C. et al. Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats. Cytotherapy 15, 869–878 (2013).

    PubMed  CAS  Google Scholar 

  81. Andersson, K. E. Detrusor underactivity/underactive bladder: new research initiatives needed. J. Urol. 184, 1829–1830 (2010).

    PubMed  Google Scholar 

  82. Wagner, G., Husslein, P. & Enzelsberger, H. Is prostaglandin E2 really of therapeutic value for postoperative urinary retention? Results of a prospectively randomized double-blind study. Am. J. Obstet. Gynecol. 151, 375–379 (1985).

    PubMed  CAS  Google Scholar 

  83. Bergman, A., Mushkat, Y., Gordon, D. & David, M. P. Prostaglandin for enhancing bladder function after vaginal surgery. Does it work? J. Reprod. Med. 37, 320–322 (1992).

    PubMed  CAS  Google Scholar 

  84. Chancellor, M. B. & Kaufman, J. Case for pharmacotherapy development for underactive bladder. Urology 72, 966–967 (2008).

    PubMed  Google Scholar 

  85. Birder, L. & Andersson, K. E. Urothelial signaling. Physiol. Rev. 93, 653–680 (2013).

    PubMed  PubMed Central  CAS  Google Scholar 

  86. Avelino, A. et al. Transient receptor potential channels in bladder function. Acta Physiol. (Oxford) 207, 110–122 (2013).

    CAS  Google Scholar 

  87. Vahabi, B. et al. TRPM8 agonists modulate contraction of the pig urinary bladder. Can. J. Physiol. Pharmacol. 91, 503–509 (2013).

    PubMed  CAS  Google Scholar 

  88. Andersson, K. E. Treatment-resistant detrusor overactivity—underlying pharmacology and potential mechanisms. Int. J. Clin. Pract. Suppl. 151, 8–16 (2006).

    CAS  Google Scholar 

  89. Molinuevo, B. & Batista-Miranda, J. E. Under the tip of the iceberg: psychological factors in incontinence. Neurourol. Urodyn. 31, 669–671 (2012).

    PubMed  Google Scholar 

  90. Kaplan, S. A. et al. Etiology of voiding dysfunction in men less than 50 years of age. Urology 47, 836–839 (1996).

    PubMed  CAS  Google Scholar 

  91. Fusco, F., Groutz, A., Blaivas, J. G., Chaikin, D. C. & Weiss, J. P. Videourodynamic studies in men with lower urinary tract symptoms: a comparison of community based versus referral urological practices. J. Urol. 166, 910–913 (2001).

    PubMed  CAS  Google Scholar 

  92. Nitti, V. W., Lefkowitz, G., Ficazzola, M. & Dixon, C. M. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures. J. Urol. 168, 135–138 (2002).

    PubMed  Google Scholar 

  93. Wang, C. C., Yang, S. S., Chen, Y. T. & Hsieh, J. H. Videourodynamics identifies the causes of young men with lower urinary tract symptoms and low uroflow. Eur. Urol. 43, 386–390 (2003).

    PubMed  Google Scholar 

  94. Kuo, H. C. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology 70, 272–276 (2007).

    PubMed  Google Scholar 

  95. Karami, H., Valipour, R., Lotfi, B., Mokhtarpour, H. & Razi, A. Urodynamic findings in young men with chronic lower urinary tract symptoms. Neurourol. Urodyn. 30, 1580–1585 (2011).

    PubMed  Google Scholar 

  96. Jeong, S. J. et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J. Urol. 53, 342–348 (2012).

    PubMed  PubMed Central  Google Scholar 

  97. Resnick, N. M., Yalla, S. V. & Laurino, E. The pathophysiology of urinary incontinence among institutionalized elderly persons. N. Engl. J. Med. 320, 1–7 (1989).

    PubMed  CAS  Google Scholar 

  98. Groutz, A. et al. Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology 54, 268–272 (1999).

    PubMed  CAS  Google Scholar 

  99. Valentini, F. A., Robain, G. & Marti, B. G. Urodynamics in women from menopause to oldest age: what motive? What diagnosis? Int. Braz. J. Urol. 37, 100–107 (2011).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors made substantial contributions to each stage of the preparation of the manuscript for submission.

Corresponding author

Correspondence to Marcus J. Drake.

Ethics declarations

Competing interests

M.J.D. declares that he is advisory board member for Apogepha. M.J.D. is an advisory board member and has received speaker bureau and research support from Allergan, Astellas, Ferring, and Pfizer. J.W. and D.A.B. declare no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drake, M., Williams, J. & Bijos, D. Voiding dysfunction due to detrusor underactivity: an overview. Nat Rev Urol 11, 454–464 (2014). https://doi.org/10.1038/nrurol.2014.156

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.156

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing